Adewole S. Adamson, MD, MPP

Article

Fixed drug eruption to medroxyprogesterone acetate

A Fixed Drug Eruption to Medroxyprogesterone Acetate Injectable Suspension

Author:: Kavina Patel, MD; Jose A. Cervantes, MD; Brett Keeling, MD; Adewole S. Adamson, MD, MPP

Exogenous progesterone from the administration of the contraceptive injectable medroxyprogesterone acetate has the potential to cause a cutaneous...

Read More

Article

Pediatric-Onset Refractory Lupus Erythematosus Panniculitis Treated With Rituximab

Author:: Divya Angra, MD; Philip A. Roehrs, MD; Paul B. Googe, MD; Adewole S. Adamson, MD, MPP

Lupus erythematosus panniculitis can be difficult to manage, as patients may not respond to conventional treatments including hydroxychloroquine...

Read More

Article

Active Comparator Trial Designs Used to Promote Development of Innovative New Medications

Author:: John S. Barbieri, MD, MBA; Jerry K.L. Tan, MD, FRCPC; Adewole S. Adamson, MD, MPP

Although some recent clinical trials in dermatology have included active comparators, many new medications continue to be introduced without any...

Read More

Article

Concordance Between Dermatologist Self-reported and Industry-Reported Interactions at a National Dermatology Conference

Author:: Hao Feng, MD, MHS; Allen F. Shih, MD, MBA; Paula Wu Feng, MD; Jennifer A. Stein, MD, PhD; Adewole S. Adamson, MD, MPP

Physician-industry interactions are prevalent. Accurate reporting allows for transparency regarding potential conflicts of interest. This study...

Read More